News
Inventors at the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are seeking a licensee or collaborator for positive allosteric modulators (PAMs) of the A 3 adenosine receptor (A 3AR), a known therapeutic target. These heterocyclic chemical compounds bind to a lipid
The Office of Intramural Research, Office of the Director, NIH, invites you to the eighth annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer. The lecture will be held on Friday, November 22, 2013, at 10:00 AM in the Lipsett Amphitheatre, Building 10, NIH
CRADA collaboration opportunities are being offered by the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) to facilitate the development of small molecule compounds early in the development cycle. Both collaborations will focus on
The 2012 Deals of Distinction™ Award was presented to National Institutes of Health (NIH) along with the University of Illinois at Chicago (UIC), who jointly own one patent family, and to Gilead Sciences (Gilead) for license agreements granted to the Medicines Patent Pool, a newly established